The potential mechanism might be explained by the expression of Angiotensin-converting-enzyme 2 (ACE2), the receptor for the COVID-19 spike protein, on pancreatic β cells can have a direct effect on β cell function, which might result in the development of diabetes among pregnant COVID-19 patients (Bornstein et al., 2020). The gene discussed is PROS1; the disease is diabetes mellitus.